You searched for "hydroxychloroquine"
Hydroxychloroquine toxicity
1 August 2017
|
Ophthalmology, EYE - Vitreo-Retinal
Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the Sword of Damocles above us...
Screening for hydroxychloroquine retinopathy
1 August 2016
| Brian Ang
|
Retina / Uvea / Vitreous
The American Academy of Ophthalmology has updated the recommendations for screening for hydroxychloroquine retinopathy based on new scientific evidence that toxicity is not rare when hydroxychloroquine is used long-term, and that risk is dependent on the daily dose by weight....
Visual fields and OCT in hydroxychloroquine retinopathy
1 October 2014
| Brian Ang
|
Retina / Uvea / Vitreous
It has been recommended that patients on hydroxychloroquine be monitored regularly for retinopathy. However, there has not been an agreement as to the best screening test for hydroxychloroquine toxicity, which may include visual fields (VF), fundus autofluorescence, spectral domain optical...
Retinal changes prior to hydroxychloroquine toxicity
1 October 2021
| Ed Rule
|
Retina / Uvea / Vitreous
|
Ganglion cell layer, Hydroxychloroquine, Optical coherence tomography, Retina, Retinal thickness
In this retrospective longitudinal study, the authors examined changes in retinal layer thickness in patients taking hydroxychloroquine without evidence of retinopathy. Patients were drawn from a hydroxychloroquine screening clinic and required at least two OCT scans, at least one year...
Learning from litigation: ocular drug toxicity
3 August 2023
| Amar Alwitry
|
Ophthalmology
Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the sword of Damocles above us...
The extended role of the specialist ophthalmic photographer
The prevalence of certain retinal conditions such as diabetic retinopathy and age-related macular degeneration (ARMD) is projected to grow substantially over the next decades. Estimates for the projected growth in burden on eye services for diabetic retinopathy and neovascular ARMD...Pathway innovations to address cataract services post-COVID-19
1 June 2022
| Sam Evans, Tine Jacobs, Hari Kaneshayogan, Leo Feinberg, Conor Ramsden
|
COVID-19, EYE - Cataract, EYE - Refractive
Background The demand for cataract services prior to the COVID-19 pandemic was already recognised to be high and growing - in the face of an ageing population and reduced surgical thresholds. When added to the growth in demand for ophthalmic...
Paraproteinaemia: a patient with atypical corneal findings
A Bence Jones protein is a monoclonal globulin protein or immunoglobulin light chain found in the urine, with a molecular weight of 22-24 kDa [1]. Detection of Bence Jones protein may be suggestive of multiple myeloma or Waldenström’s macroglobulinemia. Multiple...100% Ophthalmology Programme Insights
24 February 2024
| Samuel Verdin
|
100%, ophthalmology, Conferences, London, events, optical, optometrist
We spoke to some of the Eye News family about their upcoming presentations at 100% Opthalmology, 24–26 February 2024, ExCeL London, UK.
The results of the last survey Jun22
Thank you once more for your time in answering the latest survey. The first question relates to the number of staff required for a routine cataract list. There was a big variance in practice. Some of us are luckier than...How to be ‘appy’ on call: a brief guide to mobile phone applications for the on-call ophthalmologist
1 December 2022
| Madeleine Corkery-Hayward, Ryian Mohamed, Harry Petrushkin, David Haider
|
Ophthalmology, COVID-19
One of the unexpected outcomes of the COVID-19 pandemic has been an increased reliance and integration of computer technology within hospital medicine. The need for stricter infection control policies during and after lockdown has seen a boom in technology utilisation....